Header cover image

Global Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential

UPDATED Dec 07, 2022

Stocks with plenty of capacity to fund future growth

9 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
HZNPHorizon TherapeuticsUS$96.30-4.0%-7.4%US$21.8bUS$110.20PE38xE29.2%n/a
INCYIncyteUS$84.035.5%24.8%US$18.7bUS$87.94PE21.3xE32.3%n/a
NBIXNeurocrine BiosciencesUS$121.51-4.4%44.2%US$11.7bUS$128.97PE200.7xE39.7%n/a
EXELExelixisUS$16.35-4.3%-3.1%US$5.3bUS$26.06PE17.1xE32.0%n/a
CORTCorcept TherapeuticsUS$23.52-7.0%29.0%US$2.5bUS$35.00PE21.7xE28.3%n/a
XOMAXOMAUS$19.03-10.1%-17.9%US$217.9mUS$62.50PE22.3xE60.8%n/a
SLGLSol-Gel TechnologiesUS$4.65-1.7%-38.8%US$107.6mUS$12.50PE22xE61.0%n/a
CSBRChampions OncologyUS$6.80-1.4%-19.9%US$92.0mUS$15.33PE229.3xE93.1%n/a
LPCNLipocineUS$0.41-8.6%-63.9%US$36.4mUS$3.83PE8.9xE32.2%n/a
Page 1 of 1